Healthcare / Medical Care FacilitiesSaudi
$104.40
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $17.9M · quality 80.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$209M
P/E
11.4x
↓EV/EBITDA
7.2x
↓ROE
23.6%
↑Gross Margin
36.6%
↓Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
21.6%
FCF / Net income
0.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $83.0M · net income $18.4M · FCF $17.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $83.0M | $83.0M | $74.4M | $65.4M | — |
| Net Income | $18.4M | $18.4M | $16.7M | $12.4M | — |
| EBITDA | $27.2M | $27.2M | $22.7M | $19.4M | — |
| EPS | — | — | 8.35 | 6.18 | — |
| Gross Margin | 36.6% | 36.6% | 36.9% | 36.8% | — |
| Operating Margin | 23.3% | 23.3% | 24.4% | 23.5% | — |
| Net Margin | 22.1% | 22.1% | 22.4% | 18.9% | — |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.07 | 0.22 | 0.35 |
| Cash Flow | |||||
| Free Cash Flow | $17.9M | $17.9M | $20.6M | $11.0M | — |
| Returns | |||||
| ROE | 23.6% | 23.6% | 28.1% | 29.6% | — |
| Valuation | |||||
| P/E | 11.36 | 11.36 | 12.93 | — | — |
| EV/EBITDA | 7.17 | 7.17 | 9.05 | — | — |
| P/B | 2.69 | 2.69 | 3.64 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 11.5% | 11.5% | 13.9% | — | — |
| EPS Growth | — | — | 35.1% | — | — |
| Dividend Yield | 2.9% | 2.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.1%
Start / end P/E
n/dx → n/dx
EPS bridge
8.35 → n/d
Residual
-0.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.